newsfilter
← Latest News
PR Newswire·

Nuvation Bio to Present at the Jefferies Global Healthcare Conference in London

  • Nuvation Bio Inc. (NYSE: NUVB) announced that CEO David Hung, M.D. & CFO Philippe Sauvage will participate in a fireside chat at the Jefferies Global Healthcare Conference in London.
  • The event is scheduled for Tuesday, November 17, 2026, at 2:30 p.m. GMT.
  • A live webcast will be available on the Nuvation Bio Investor Relations website, with an archived recording accessible for 90 days post-event.
  • The company's pipeline includes taletrectinib (IBTROZI®), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor; & a drug-drug conjugate program.
  • Nuvation Bio was founded in 2018 by David Hung, M.D., who previously founded Medivation, Inc., & maintains offices in New York, San Francisco, Boston, & Shanghai.
  • Investor contact is JR DeVita, & media contact is Kaitlyn Nealy.
Company
Nuvation Bio, Inc.
Keywords
Nuvation Bio, Inc.